A Multicenter, Phase Ib/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

被引：0
|
作者：
Casasanta, Nicole
Landry, Chrystal
Shao, Theresa
Klein, Paula
Fasano, Julie
Bhardwaj, Aarti
Berger, Natalie
Moshier, Erin
Joshi, Gargi Atul
Vaccaro, Rita
Sparano, Joseph
Tiersten, Amy
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-19-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-19-11
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
    Tolaney, Sara M.
    Beeram, Muralidhar
    Beck, J. Thaddeus
    Conlin, Alison
    Dees, E. Claire
    Puhalla, Shannon L.
    Rexer, Brent N.
    Burris, Howard A., III
    Jhaveri, Komal
    Helsten, Teresa
    Becerra, Carlos
    Kalinsky, Kevin
    Moore, Kathleen N.
    Manuel, Allison M.
    Lithio, Andrew
    Price, Gregory L.
    Chapman, Sonya C.
    Litchfield, Lacey M.
    Goetz, Matthew P.
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [2] Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
    Gucalp, Ayca
    Tolaney, Sara
    Isakoff, Steven J.
    Ingle, James N.
    Liu, Minetta C.
    Carey, Lisa A.
    Blackwell, Kimberly
    Rugo, Hope
    Nabell, Lisle
    Forero, Andres
    Stearns, Vered
    Doane, Ashley S.
    Danso, Michael
    Moynahan, Mary Ellen
    Momen, Lamia F.
    Gonzalez, Joseph M.
    Akhtar, Arooj
    Giri, Dilip D.
    Patil, Sujata
    Feigin, Kimberly N.
    Hudis, Clifford A.
    Traina, Tiffany A.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5505 - 5512
  • [3] Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the lines
    Matutino, A.
    Joy, A. A.
    Brezden-Masley, C.
    Chia, S.
    Verma, S.
    CURRENT ONCOLOGY, 2018, 25 : S131 - S141
  • [4] Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Morikawa, Aki
    Henry, N. Lynn
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3591 - 3596
  • [5] Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive, HER2-Negative Metastatic/Recurrent Breast Cancer
    Go, Makiko
    Kimura, Michio
    Yamada, Shiori
    Usami, Eiseki
    Noguchi, Yoshihiro
    Yoshimura, Tomoaki
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (06) : 1258 - 1266
  • [6] Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort
    Novik, Y.
    Klar, N.
    Zamora, S.
    Kwa, M.
    Speyer, J.
    Oratz, R.
    Muggia, F.
    Meyers, M.
    Hochman, T.
    Goldberg, J.
    Adams, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S59 - S59
  • [7] Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancer
    Shah, Ami N.
    Flaum, Lisa
    Helenowski, Irene
    Santa-Maria, Cesar A.
    Jain, Sarika
    Rademaker, Alfred
    Nelson, Valerie
    Tsarwhas, Dean
    Cristofanilli, Massimo
    Gradishar, William
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [8] A phase Ib trial of xentuzumab and abemaciclib in patients with locally advanced or metastatic solid tumors, including hormone receptor-positive, HER2-negative breast cancer (plus endocrine therapy)
    Yee, Douglas
    Sablin, Marie Paule
    Iwata, Hiroji
    Johnston, Erica L.
    Bogenrieder, Thomas
    Serra, Josep
    Hua, Hairui
    Lo Russo, Patricia
    Prat, Aleix
    CANCER RESEARCH, 2018, 78 (04)
  • [9] Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer
    Pietri, Elisabetta
    Massa, Ilaria
    Bravaccini, Sara
    Ravaioli, Sara
    Tumedei, Maria Maddalena
    Petracci, Elisabetta
    Donati, Caterina
    Schirone, Alessio
    Piacentini, Federico
    Gianni, Lorenzo
    Nicolini, Mario
    Campadelli, Enrico
    Gennari, Alessandra
    Saba, Alessandro
    Campi, Beatrice
    Valmorri, Linda
    Andreis, Daniele
    Fabbri, Francesco
    Amadori, Dino
    Rocca, Andrea
    ONCOLOGIST, 2019, 24 (06): : 743 - E205
  • [10] Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis
    Taniguchi, Azusa
    Kittaka, Nobutohi
    Kanaoka, Haruka
    Nakajima, Satomi
    Oyama, Yuri
    Seto, Yukiko
    Soma, Ai
    Kusama, Hiroki
    Watanabe, Noriyuki
    Matsui, Saki
    Nishio, Minako
    Fujisawa, Fumie
    Nakayama, Takahiro
    ANTICANCER RESEARCH, 2022, 42 (12) : 6027 - 6035
12345